Willie Wang

Sep 1, 2024 | biorxiv.org | Kai Liu |Yao Yu |Edward Hsieh |Willie Wang

AbstractThe shift towards the subcutaneous administration route for biologics therapeutics has gained momentum due to its patient-friendly nature, convenience, reduced healthcare burden, and improved compliance compared to traditional intravenous infusions. However, one of the potentially significant challenges with this transition is managing the viscosity of the administered solutions.